A Diabetes RELIEF Initiative: Realizing the Potential of GLP-1 Receptor Agonists in Type 2 Diabetes: Partnering with Patients to Improve Glycemic and Cardiovascular Outcomes
Podcast 1: Newly Diagnosed Diabetes with Dr. Pratley
Post-Test/Evaluation

Questions marked with a * are required

24%

Contact Information

First Name

Last Name

Email Address

Credentials/Degree (MD, DO, RN, etc.)

Date of Participation

Charlie is a 54-year-old man with +ASCVD and newly diagnosed with diabetes. For high-risk patients with type 2 diabetes, the goal of cardiorenal risk reduction may be achieved with which of the following medications?

A. Sulfonylureas

B. DPP-4 inhibitors

C. SGLT-2 inhibitors

D. GLP-1 receptor agonists

E. C and D

Betty is an 85 year-old woman who lives alone. She has a history of multiple endocrine neoplasia syndrome type 2. Which medications would be contraindicated in this patient?

A. Sulfonylureas

B. DPP-4 inhibitors

C. SGLT-2 inhibitors

D. GLP-1 receptor agonists

Frank is a 62-year-old man who recently retired and moved in with his daughter and her children. He has a strong family history of diabetes and is newly diagnosed with type 2 diabetes. His daughter accompanies him to his first visit to the endocrinologist. According to the ADA, which of the following should be included in his management plan?

A. Ensure access to DSMES

B. Involve an educated and informed person (and the individual's family/caregiver)

C. Discuss the patient’s personal preferences

D. Include motivational interviewing, goal setting, and shared decision making

E. All of the above